Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Protocol to assess the antitumor efficacy of an immunotherapeutic peptide in syngeneic orthotopic glioma mouse models

STAR Protocols(2023)10.1016/j.xpro.2023.102049Source: DataRank Database

Protocol to assess the antitumor efficacy of an immunotherapeutic peptide in syngeneic orthotopic glioma mouse models is a research paper published in STAR Protocols (2023). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

Linked data & code

gen cellosaurus

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)OA: goldTopics (26)IDs (PubMed, PMC)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Yapeng Chao ORCID,Han Zou ORCID,Lauren McCarl ORCID,Gary Kohanbash ORCID,Baoli Hu ORCID

Live enrichment

PubMed:36861832 PMC:PMC10037209

National Natural Science Foundation of China

Grant: 32273019

Central Public-interest Scientific Institution Basal Research Fund, Chinese Academy of Fishery Sciences

Grant: 110231160042015

National Institute of Neurological Disorders and Stroke

Grant: 1R21NS125218

Natural Science Foundation of Gansu Province

Grant: 22JR5RA028

National Cancer Institute

Grant: / NCI 1R01CA259124

NINDS NIH HHS

Grant: R21 NS125218

NCI NIH HHS

Grant: R01 CA259124

National Institutes of Health

Grant: 1R01CA259124-01A1

Chitinase-3-like-1 mediated immunosuppression in Glioblastoma

National Institutes of Health

Grant: 5R01LM013039-02

HealthyMe/MiSalud Smartphone Application: Identifying Mechanisms to Engage African Americans and Hispanics in Personal Health Libraries

National Institutes of Health

Grant: 1R21NS125218-01

Role of SMARCD3/BAF60C in neurodevelopment and medulloblastoma

National Institutes of Health

Children's Hospital of Pittsburgh

goldLicense: cc-by-nc-nd

publisherhttps://doi.org/10.1016/j.xpro.2023.102049

publisherhttps://api.elsevier.com/content/article/PII:S2666166723000072?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666166723000072?httpAccept=text/plain

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10037209/pdf/main.pdf

repositoryhttps://doaj.org/article/3c206ee7b98a469e817eea6b1b057479

Fields of Study

0301 basic medicine03 medical and health sciences0302 clinical medicine

MeSH Terms

Cell Line, TumorAnimalsMiceGliomaGlioblastomaDisease Models, AnimalImmunotherapyTumor Microenvironment

Keywords

CancerNeuroscienceHealth SciencesModel OrganismsScience (General)GliomaQ1-390MiceDisease Models, AnimalCell Line, TumorProtocolTumor MicroenvironmentAnimalsImmunotherapyGlioblastoma